NCT07072234 2026-04-29Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell CarcinomaM.D. Anderson Cancer CenterPhase 1 Recruiting30 enrolled